Cargando…
Natural products, PGC-1α, and Duchenne muscular dystrophy
Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the o...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276681/ https://www.ncbi.nlm.nih.gov/pubmed/32528825 http://dx.doi.org/10.1016/j.apsb.2020.01.001 |
_version_ | 1783543000468553728 |
---|---|
author | Suntar, Ipek Sureda, Antoni Belwal, Tarun Sanches Silva, Ana Vacca, Rosa Anna Tewari, Devesh Sobarzo-Sánchez, Eduardo Nabavi, Seyed Fazel Shirooie, Samira Dehpour, Ahmad Reza Xu, Suowen Yousefi, Bahman Majidinia, Maryam Daglia, Maria D'Antona, Giuseppe Nabavi, Seyed Mohammad |
author_facet | Suntar, Ipek Sureda, Antoni Belwal, Tarun Sanches Silva, Ana Vacca, Rosa Anna Tewari, Devesh Sobarzo-Sánchez, Eduardo Nabavi, Seyed Fazel Shirooie, Samira Dehpour, Ahmad Reza Xu, Suowen Yousefi, Bahman Majidinia, Maryam Daglia, Maria D'Antona, Giuseppe Nabavi, Seyed Mohammad |
author_sort | Suntar, Ipek |
collection | PubMed |
description | Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1α are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1α is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPARγ activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1α. |
format | Online Article Text |
id | pubmed-7276681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72766812020-06-10 Natural products, PGC-1α, and Duchenne muscular dystrophy Suntar, Ipek Sureda, Antoni Belwal, Tarun Sanches Silva, Ana Vacca, Rosa Anna Tewari, Devesh Sobarzo-Sánchez, Eduardo Nabavi, Seyed Fazel Shirooie, Samira Dehpour, Ahmad Reza Xu, Suowen Yousefi, Bahman Majidinia, Maryam Daglia, Maria D'Antona, Giuseppe Nabavi, Seyed Mohammad Acta Pharm Sin B Review Peroxisome proliferator-activated receptor γ (PPARγ) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPARγ coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1α are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1α is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPARγ activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1α. Elsevier 2020-05 2020-01-08 /pmc/articles/PMC7276681/ /pubmed/32528825 http://dx.doi.org/10.1016/j.apsb.2020.01.001 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Suntar, Ipek Sureda, Antoni Belwal, Tarun Sanches Silva, Ana Vacca, Rosa Anna Tewari, Devesh Sobarzo-Sánchez, Eduardo Nabavi, Seyed Fazel Shirooie, Samira Dehpour, Ahmad Reza Xu, Suowen Yousefi, Bahman Majidinia, Maryam Daglia, Maria D'Antona, Giuseppe Nabavi, Seyed Mohammad Natural products, PGC-1α, and Duchenne muscular dystrophy |
title | Natural products, PGC-1α, and Duchenne muscular dystrophy |
title_full | Natural products, PGC-1α, and Duchenne muscular dystrophy |
title_fullStr | Natural products, PGC-1α, and Duchenne muscular dystrophy |
title_full_unstemmed | Natural products, PGC-1α, and Duchenne muscular dystrophy |
title_short | Natural products, PGC-1α, and Duchenne muscular dystrophy |
title_sort | natural products, pgc-1α, and duchenne muscular dystrophy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276681/ https://www.ncbi.nlm.nih.gov/pubmed/32528825 http://dx.doi.org/10.1016/j.apsb.2020.01.001 |
work_keys_str_mv | AT suntaripek naturalproductspgc1aandduchennemusculardystrophy AT suredaantoni naturalproductspgc1aandduchennemusculardystrophy AT belwaltarun naturalproductspgc1aandduchennemusculardystrophy AT sanchessilvaana naturalproductspgc1aandduchennemusculardystrophy AT vaccarosaanna naturalproductspgc1aandduchennemusculardystrophy AT tewaridevesh naturalproductspgc1aandduchennemusculardystrophy AT sobarzosanchezeduardo naturalproductspgc1aandduchennemusculardystrophy AT nabaviseyedfazel naturalproductspgc1aandduchennemusculardystrophy AT shirooiesamira naturalproductspgc1aandduchennemusculardystrophy AT dehpourahmadreza naturalproductspgc1aandduchennemusculardystrophy AT xusuowen naturalproductspgc1aandduchennemusculardystrophy AT yousefibahman naturalproductspgc1aandduchennemusculardystrophy AT majidiniamaryam naturalproductspgc1aandduchennemusculardystrophy AT dagliamaria naturalproductspgc1aandduchennemusculardystrophy AT dantonagiuseppe naturalproductspgc1aandduchennemusculardystrophy AT nabaviseyedmohammad naturalproductspgc1aandduchennemusculardystrophy |